JENNIFER DYKHOUSE: Open Payments
NPI 1881769321 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 105 payments from 24 companies in 2025. Trend: 2023 $1,503 · 2024 $1,436 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $242 |
| Novartis Pharmaceuticals Corporation | 16 | $194 |
| E.R. Squibb & Sons, L.L.C. | 17 | $191 |
| Amgen Inc. | 10 | $154 |
| PFIZER INC. | 7 | $144 |
| Merck Sharp & Dohme LLC | 4 | $124 |
| BridgeBio Pharma, Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $62 |
| ABIOMED | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
Products named: LEQVIO, Wegovy, Repatha, CAMZYOS, VYNDAQEL, VERQUVO, Attruby, Ozempic.
Industry payments across MI — which companies pay providers there.
